|
US7395158B2
(en)
*
|
2000-05-30 |
2008-07-01 |
Sensys Medical, Inc. |
Method of screening for disorders of glucose metabolism
|
|
US20040236673A1
(en)
|
2000-10-17 |
2004-11-25 |
Eder Jeff Scott |
Collaborative risk transfer system
|
|
CA2331116A1
(en)
|
2001-01-15 |
2002-07-15 |
Chenomx, Inc. |
Compound identification and quantitation in liquid mixtures -- method and process using an automated nuclear magnetic resonance measurement system
|
|
EP1384073A2
(en)
*
|
2001-04-23 |
2004-01-28 |
Metabometrix Limited |
Methods for analysis of spectral data and their applications: osteoporosis
|
|
US7901873B2
(en)
|
2001-04-23 |
2011-03-08 |
Tcp Innovations Limited |
Methods for the diagnosis and treatment of bone disorders
|
|
US20040142403A1
(en)
*
|
2001-08-13 |
2004-07-22 |
Donald Hetzel |
Method of screening for disorders of glucose metabolism
|
|
EP1444526B1
(en)
|
2001-11-13 |
2011-09-21 |
The Regents of The University of California |
Ion mobility analysis of biological particles
|
|
US6873914B2
(en)
|
2001-11-21 |
2005-03-29 |
Icoria, Inc. |
Methods and systems for analyzing complex biological systems
|
|
US6862592B1
(en)
*
|
2001-12-21 |
2005-03-01 |
Adobe Systems Incorporated |
Document processing in a cross-platform environment
|
|
EP1329716A1
(en)
*
|
2002-01-16 |
2003-07-23 |
Roche Diagnostics GmbH |
Method for screening biological samples for presence of the metabolic syndrome
|
|
US7426499B2
(en)
*
|
2004-11-08 |
2008-09-16 |
Asset Trust, Inc. |
Search ranking system
|
|
US20070011049A1
(en)
*
|
2005-07-09 |
2007-01-11 |
Eder Jeffrey S |
Intelligent, personalized commerce chain
|
|
US7730063B2
(en)
*
|
2002-12-10 |
2010-06-01 |
Asset Trust, Inc. |
Personalized medicine service
|
|
US20080027769A1
(en)
*
|
2002-09-09 |
2008-01-31 |
Jeff Scott Eder |
Knowledge based performance management system
|
|
WO2004040407A2
(en)
*
|
2002-10-25 |
2004-05-13 |
Liposcience, Inc. |
Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals
|
|
DE10315877B4
(de)
*
|
2003-04-08 |
2005-11-17 |
Roche Diagnostics Gmbh |
Krankheitsverlaufkontrolle
|
|
US8460243B2
(en)
*
|
2003-06-10 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Glucose measuring module and insulin pump combination
|
|
US7722536B2
(en)
*
|
2003-07-15 |
2010-05-25 |
Abbott Diabetes Care Inc. |
Glucose measuring device integrated into a holster for a personal area network device
|
|
US7197427B2
(en)
*
|
2004-03-31 |
2007-03-27 |
Genworth Financial Inc. |
Method for risk based testing
|
|
CA2561536C
(en)
*
|
2004-04-01 |
2017-09-19 |
Liposcience, Inc. |
Nmr clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
|
|
US7422224B2
(en)
*
|
2004-04-13 |
2008-09-09 |
Kimir Seatpost |
Adjustable bicycle seat post assembly
|
|
US20060010098A1
(en)
|
2004-06-04 |
2006-01-12 |
Goodnow Timothy T |
Diabetes care host-client architecture and data management system
|
|
US7951078B2
(en)
*
|
2005-02-03 |
2011-05-31 |
Maren Theresa Scheuner |
Method and apparatus for determining familial risk of disease
|
|
ATE412364T1
(de)
|
2005-03-15 |
2008-11-15 |
Hoffmann La Roche |
Verfahren und system zur untersuchung des glucosestoffwechsels
|
|
ES2525345T3
(es)
*
|
2006-03-24 |
2014-12-22 |
Metanomics Gmbh |
Procedimiento de diagnóstico de diabetes de tipo II
|
|
US8498915B2
(en)
*
|
2006-04-02 |
2013-07-30 |
Asset Reliance, Inc. |
Data processing framework for financial services
|
|
US8247235B2
(en)
|
2007-06-08 |
2012-08-21 |
Quest Diagnostics Investments Incorporated |
Lipoprotein analysis by differential charged-particle mobility
|
|
TW200936156A
(en)
|
2008-01-28 |
2009-09-01 |
Novartis Ag |
Methods and compositions using Klotho-FGF fusion polypeptides
|
|
US8420088B2
(en)
|
2008-01-28 |
2013-04-16 |
Novartis Ag |
Methods and compositions using FGF23 fusion polypeptides
|
|
US9354200B1
(en)
|
2008-08-07 |
2016-05-31 |
Quest Diagnostics Investments Incorporated |
Detection apparatus for differential-charged particle mobility analyzer
|
|
US8386187B2
(en)
*
|
2008-10-20 |
2013-02-26 |
Liposcience, Inc. |
Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same
|
|
DE102009026651A1
(de)
|
2009-06-02 |
2011-02-17 |
Großmann, Kay, Dr. rer. nat. (Chemie) |
Verfahren und Messvorrichtung zur qualitativen und quantitativen Analyse von Körperflüssigkeiten
|
|
US9250211B2
(en)
|
2010-12-30 |
2016-02-02 |
Quest Diagnostics Investments Incorporated |
Magnetic separation of lipoproteins using dextran sulfate
|
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
|
WO2012163361A1
(en)
*
|
2011-05-31 |
2012-12-06 |
Aarhus Universitet |
Method and system for identification of physiological imbalance in an animal
|
|
EP3686620A1
(en)
|
2011-06-30 |
2020-07-29 |
Liposcience, Inc. |
Quantitative nmr clinical analyzers with automatic nmr temperature sensitivity compensation that accommodate large ambient operational temperature ranges
|
|
WO2013027191A1
(en)
|
2011-08-25 |
2013-02-28 |
Novartis Ag |
Methods and compositions using fgf23 fusion polypeptides
|
|
US9928345B2
(en)
|
2012-06-08 |
2018-03-27 |
Liposciences, Inc. |
Multiple-marker risk parameters predictive of conversion to diabetes
|
|
US9470771B2
(en)
|
2012-06-08 |
2016-10-18 |
Liposcience, Inc. |
NMR measurements of NMR biomarker GlycA
|
|
US9361429B2
(en)
*
|
2012-06-08 |
2016-06-07 |
Liposcience, Inc. |
Multi-parameter diabetes risk evaluations
|
|
US20150260631A1
(en)
*
|
2014-03-17 |
2015-09-17 |
Health Diagnostic Laboratory, Inc. |
System and method for assessing quanitites or sizes of lipoprotein particles from lipoprotein particle compositions
|
|
US9551768B2
(en)
|
2013-03-15 |
2017-01-24 |
East Carolina University |
NMR method for monitoring changes in the core of lipoprotein particles in metabolism and disease
|
|
DE102014203721B4
(de)
*
|
2014-02-28 |
2018-12-27 |
Bruker Biospin Gmbh |
Verfahren zur Bestimmung der Konzentration einer Substanz in einer Probe
|
|
EP3210029A1
(en)
|
2014-10-21 |
2017-08-30 |
True Health IP LLC |
Quantitative molar concentration detection of specific apolipoprotein-containing particles present in bodily fluids by using capillary electrophoresis
|
|
US20160109471A1
(en)
|
2014-10-21 |
2016-04-21 |
Health Diagnostic Laboratory, Inc. |
Lipoprotein particle number from measurements of lipoprotein particle phospholipid concentration in lipoprotein particle membrane bilayer
|
|
WO2016069639A1
(en)
|
2014-10-27 |
2016-05-06 |
True Health Diagnostics, Llc |
Lp(a) subform size identification by capillary isoteachophoresis electrophoresis with laser-induced-fluorescence
|
|
WO2016088059A1
(en)
|
2014-12-04 |
2016-06-09 |
Novartis Ag |
Methods and compositions using klotho variant polypeptides
|
|
US11156621B2
(en)
*
|
2017-09-07 |
2021-10-26 |
Liposcience, Inc. |
Multi-parameter metabolic vulnerability index evaluations
|
|
US10775458B2
(en)
|
2018-03-05 |
2020-09-15 |
Texas Tech University System |
Method and system for non-invasive measurement of metabolic health
|
|
WO2023239869A1
(en)
*
|
2022-06-09 |
2023-12-14 |
Quest Diagnostics Investments Llc |
Quantification of lipoprotein subfractions by ion mobility
|
